Spruce Medimaging
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Spruce Medimaging - overview
Established
2022
Location
Beijing, -, China
Primary Industry
Healthcare IT
About
Founded in 2022 and based in Beijing, China, Spruce Medimaging operates as a medical company that focuses on providing clinical medicine evaluation services. It acquired ISO-13485 quality management system certification and ISO-27001 quality management system certification. The company cooperated with Yizhong Pharma, Ausun Pharm, Fosun Pharma, and other enterprises. In August 2024, Spruce Medimaging closed a series A funding.
The company is mainly engaged in independent imaging evaluation (IRC) services for innovative drug clinical research centers. The business covers medical imaging evaluation, clinical medicine evaluation, and eligibility evaluation of clinical research subjects for doctors and pharmaceutical companies. Its image types include CT, MRI, and X-Ray, which adopt technical platforms such as medical imaging, clinical data, and medical AI. The target customers of the company are medical institutions, biopharmaceutical companies, and medical device companies.
The company generates revenue by providing clinical medicine evaluation and related services. The company will use the series A funding to upgrade SPRUCE medical imaging assessment systems, improve the international standard system, recruit teams, expand the application areas of independent imaging IRC, and expand the market.
Current Investors
Ken Capital, Taikun Fund, Yingke Private Equity
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Monitoring Equipment, Analytics & Performance Software, Medical Software
Website
www.medspruce.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.